1. Home
  2. DLPN vs TPST Comparison

DLPN vs TPST Comparison

Compare DLPN & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.52

Market Cap

17.8M

ML Signal

HOLD

Logo Tempest Therapeutics Inc.

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$3.03

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
TPST
Founded
1996
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
14.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DLPN
TPST
Price
$1.52
$3.03
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$12.50
AVG Volume (30 Days)
37.7K
179.2K
Earning Date
11-12-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,371,115.00
N/A
Revenue This Year
$10.62
N/A
Revenue Next Year
$13.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$0.75
$2.87
52 Week High
$1.88
$13.65

Technical Indicators

Market Signals
Indicator
DLPN
TPST
Relative Strength Index (RSI) 37.11 28.35
Support Level $1.41 $2.87
Resistance Level $1.65 $3.20
Average True Range (ATR) 0.09 0.16
MACD -0.02 0.25
Stochastic Oscillator 17.27 27.03

Price Performance

Historical Comparison
DLPN
TPST

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Share on Social Networks: